The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 23, 2014
Filed:
Jun. 11, 2010
Daniel Romo, College Station, TX (US);
Jun Liu, Clarksville, MD (US);
Nam Song Choi, Cheonan, KR;
Zonggao Shi, Columbia, MD (US);
Woon-kai Low, Baltimore, MD (US);
Yongjun Dang, Baltimore, MD (US);
Tilman Schneider-poetsch, Erftstadt, DE;
Daniel Romo, College Station, TX (US);
Jun Liu, Clarksville, MD (US);
Nam Song Choi, Cheonan, KR;
Zonggao Shi, Columbia, MD (US);
Woon-Kai Low, Baltimore, MD (US);
Yongjun Dang, Baltimore, MD (US);
Tilman Schneider-Poetsch, Erftstadt, DE;
The Texas A&M University System, College Station, TX (US);
The John Hopkins University, Baltimore, MD (US);
Abstract
Provided herein include compositions, all related stereoisomers as well as pharmaceutically acceptable salts provided as simplified analogs of pateamine A, in which the analogs generally are devoid of the C3-amino and C5-methyl groups, also referred to as desmethyl, desamino-pateamine A. Suitable analogs provide anticancer and antiproliferative effects in vivo and in vitro by a novel drugs mechanism of action described herein for pateamine A, including inhibition of eIF4A-dependent translation initiation. As with pateamine A, as described herein, suitable analogs cause cell cycle arrest or induce apoptosis in transformed cells. However, toxicity of such compounds to slow growing normal cells is low. In addition, such analogs, like pateamine A, target translation initiation factors and are useful as anticancer and antiproliferative agents in subjects in need thereof. Moreover, the analogs, like pateamine A, are valuable molecular probes for evaluation of eukaryotic translation initiation and as lead compounds for development of improved anticancer agents.